NCT07054398View on ClinicalTrials.gov

Assessment of Serum Catestatin Level in Acne Vulgaris Patients

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 10, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

January 10, 2026

Conditions
Acne Vulgaris
Interventions
DRUG

Isotretinoin

"* Measure the serum levels of catestatin in patients with moderate and severe acne vulgaris versus healthy control persons.~* Evaluate the effect of oral isotretinoin treatment on serum catestatin levels in patients with moderate and severe acne vulgaris."

Trial Locations (1)

Unknown

RECRUITING

Aswan Unuversity Hospital, Aswān

All Listed Sponsors
lead

Aswan University

OTHER